Skip to main content
. 2021 Mar 26;11(4):199. doi: 10.3390/metabo11040199

Figure 3.

Figure 3

Heatmap illustrating the levels of urinary volatile metabolites changing between NMIBC (stage Ta/Tis and T1) and MIBC (stages ≥T2) patients. Columns correspond to each sample group, while rows correspond to the mean normalized peak area of each discriminant volatile metabolite colored from minimum (−1, dark blue) to maximum (1, dark red).